We serve Chemical Name:Sodium cyclamate CAS:139-05-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Sodium cyclamate
CAS.NO:139-05-9
Synonyms:SodiuM N-CyclohexylsulfaMate;MFCD00003827;ibiosuc;N-Cyclohexanesulfamic Acid Sodium Salt;N-Cyclohexylsulfamic Acid Sodium Salt;cyclamic;Sodium cyclamate;sucrum7;EINECS 205-348-9;sodium cyclohexanesulfamate;sugarin;asugryn;sugaron;Acofarinas;sodium cyclohexylsulphamate;Natriumcyclamat;CYCLAMATE;suessette;Sodium N-Cyclohexanesulfamate;suestamin;sodium cyclohexylsulfamate
Molecular Formula:C6H12NNaO3S
Molecular Weight:201.219
HS Code:2929901000
Physical and Chemical Properties:
Melting point:>300 °C(lit.)
Boiling point:N/A
Density:1.32g/cm3
Index of Refraction:
PSA:77.61000
Exact Mass:201.043564
LogP:1.84060
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like SodiuM N-CyclohexylsulfaMate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,sodium cyclohexylsulfamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,sodium cyclohexylsulphamate Use and application,suessette technical grade,usp/ep/jp grade.
Related News: Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. {(S)-1-[((S)-Cyano-methyl-methyl)-methyl-carbamoyl]-2,2-dimethyl-propyl}-carbamic acid tert-butyl ester manufacturers This project is supported by the Irish Government through IDA Ireland. (1-methylpiperidin-1-ium-3-yl)methyl 2-methoxy-2,2-diphenylacetate,chloride suppliers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. (3-propan-2-ylphenyl) N-diethoxyphosphinothioyl-N-methylcarbamate vendor & factory.
